All Articles

Bigleaf and CSG are rewriting the rules of business internet, combining 5G and Starlink not for backup, but for a unified, high-performance connection.

Mars hits a 100% renewable US energy milestone, but is it a true blueprint for corporate climate action? A deep dive into the story behind the numbers.

As Latus Bio advances its Huntington's therapy to clinic, new CBO Bethany Mancilla brings a history of high-value deals to fuel the company's growth.

A new survey reveals an overwhelming public demand to treat epinephrine like defibrillators. This isn't just about allergies; it's a systemic shift in our definition of public safety.

A rebrand, a football partnership, and a $25,000 cheque. Western Financial Group’s recent event is a case study in how to turn corporate strategy into local good.

Strive Health's new CMO and CFO hires signal a strategic acceleration in value-based kidney care, blending clinical innovation with financial AI deployment.

Biotech firm ProJenX reports its novel ALS drug, prosetin, is safe and hits key targets in early trials, offering a new beacon of hope for the disease.

A single soldier controlling a swarm of drones in a contested battle. Palladyne AI's recent test with the U.S. Army signals a major leap in autonomy.

A major deal between Aeva and Bendix brings advanced 4D LiDAR to commercial trucking, promising enhanced safety and signaling a major shift in the ADAS industry.

At SHRM26, V2 Cloud launched an AI assistant and a performance-assured VDI, aiming to give HR leaders a secure, easy-to-use toolkit for modern work.

Beyond the awards, a Texas healthcare giant’s investment in paid leave and remote work reveals a powerful strategy for talent retention and market leadership.

With $10M in funding, Magnitude launches an autonomous AI workforce to combat machine-speed threats, forcing a reckoning in third-party risk management.

A new silicon battery from Coreshell promises a 30% performance boost and a domestic supply chain, aiming to secure U.S. military technology from foreign risk.

Pasithea Therapeutics is expanding its NF1 trial for PAS-004, a move that signals a deeper strategic commitment to outmaneuvering competitors and meeting a critical unmet medical need.

Tiny biotech HCW Biologics reports promising early data for its alopecia drug. But with a small sample size and big pharma rivals, is this a true breakthrough?

German firm NVision wins a top award for POLARIS, a quantum-enhanced MRI platform that shows if cancer therapy is working weeks or months sooner.

With a third consecutive GigaOm Leader nod, Scale Computing isn't just innovating; it's defining the future of distributed enterprise IT. What's their secret?

A new report reveals that team relationships and good managers are now the top retention drivers in the restaurant industry, not just paychecks.

A new partnership puts Abaxx's future-focused commodity data on 400,000 screens. Is this the move that makes LNG and battery metal markets truly tradable?

Aya Gold & Silver's inclusion in the GDX Gold Miners ETF marks a major milestone, validating its explosive growth and strategic execution at its Moroccan mines.